INSULIN RESISTANCE
THE hidden WAY car emissions CAN KILL YOU.
Traffic pollution invades your home—triggering respiratory distress often mistaken for bad indoor air or asthma, while hidden toxins silently block your body’s smallest blood vessels.
Children are among those particularly vulnerable to traffic-related air pollution.
ATP
ATP is the primary energy molecule used by cells. Nearly all cellular functions — including muscle activity, nerve signaling, and repair processes — depend on ATP availability.
Carbon monoxide (CO)
Carbon monoxide is a gas that binds strongly to hemoglobin and interferes with oxygen transport. Even low-level exposure can reduce oxygen delivery to tissues and increase physiological stress.
Cellular energy production
Cellular energy production refers to the processes cells use to generate ATP. Under normal conditions, this mainly occurs through oxygen-dependent mitochondrial respiration.
Chronic hypoxia
Chronic hypoxia means tissues experience long-term reduced oxygen availability. This can force the body into continuous compensatory stress responses and altered metabolism.
Circulation
Circulation is the movement of blood through the body. It delivers oxygen and nutrients to tissues while removing carbon dioxide and waste products.
Compensatory mechanism
A compensatory mechanism is the body’s attempt to maintain stability during dysfunction or stress. These responses may help temporarily, but chronic compensation can eventually contribute to symptoms.
Dysautonomia
Dysautonomia refers to dysfunction of the autonomic nervous system. It can affect heart rate, blood pressure, circulation, digestion, temperature regulation, and stress responses.
Endothelial dysfunction
Endothelial dysfunction means the inner lining of blood vessels no longer regulates circulation normally. This can impair blood flow control, oxygen delivery, vascular relaxation, and microcirculation.
Endothelium
The endothelium is the thin inner lining of blood vessels. It plays a central role in regulating blood flow, vascular tone, inflammation, and oxygen delivery.
Energy deficit
An energy deficit occurs when cells cannot produce enough ATP to meet demand. This can contribute to fatigue, reduced physical capacity, impaired recovery, and physiological stress.
Glycolysis
Glycolysis is a form of energy production that does not require oxygen. It is less efficient than mitochondrial respiration and produces lactate as a byproduct.
Hypoxia
Hypoxia means insufficient oxygen availability at the tissue level. Even when blood oxygen appears normal, impaired circulation can still create localized hypoxia.
Insulin resistance
Insulin resistance occurs when cells respond poorly to insulin signaling. This disrupts glucose regulation and is commonly associated with metabolic dysfunction.
Lactic acid
Lactic acid is produced when cells rely more heavily on glycolysis for energy production. Increased lactic acid production can occur during hypoxia or impaired oxygen utilization.
Lactate
Lactate is a metabolic byproduct generated during glycolysis. Elevated lactate levels may indicate increased reliance on anaerobic energy production.
Metabolic dysfunction
Metabolic dysfunction refers to impaired regulation of energy production and cellular metabolism. It can affect glucose handling, mitochondrial function, circulation, and stress physiology.
Metabolism
Metabolism includes all chemical processes required to maintain cellular function and energy production. It involves how the body uses oxygen, nutrients, and energy.
Microcirculation
Microcirculation refers to blood flow through the body’s smallest vessels, including capillaries. This system is critical for oxygen delivery directly to tissues.
Microvascular dysfunction
Microvascular dysfunction means small blood vessels no longer regulate blood flow properly. This can create uneven oxygen delivery and localized tissue stress.
Mitochondria
Mitochondria are structures inside cells responsible for most ATP production. They generate energy primarily through oxygen-dependent metabolism.
Nitric oxide (NO)
Nitric oxide is a signaling molecule that helps blood vessels relax and regulate circulation. Reduced nitric oxide activity can contribute to vascular dysfunction and impaired blood flow.
Oxidative phosphorylation
Oxidative phosphorylation is the mitochondria’s primary oxygen-dependent energy production pathway. It produces large amounts of ATP under normal physiological conditions.
Oxidative stress
Oxidative stress occurs when reactive oxygen species exceed the body’s antioxidant defenses. Excess oxidative stress can damage cells, blood vessels, and cellular signaling systems.
Oxygen delivery
Oxygen delivery refers to the transport of oxygen from the lungs to tissues. This depends on blood flow, hemoglobin function, vascular regulation, and microcirculation.
Parasympathetic nervous system
The parasympathetic nervous system supports recovery, repair, digestion, and energy conservation. It is often described as the body’s “rest and recovery” system.
Perfusion
Perfusion refers to blood flow reaching tissues and organs. Reduced perfusion can impair oxygen and nutrient delivery even when circulation is still present.
Physiological stress
Physiological stress refers to biological strain placed on the body. This can result from impaired oxygen delivery, metabolic imbalance, inflammation, or chronic compensation.
Redox balance
Redox balance refers to the balance between oxidation and antioxidant defense systems. Disruption of redox balance can contribute to oxidative stress and cellular dysfunction.
Sympathetic nervous system
The sympathetic nervous system activates the body’s stress response. It increases heart rate, blood pressure, alertness, and circulatory compensation during physiological stress.
Tissue hypoxia
Tissue hypoxia means specific tissues are not receiving sufficient oxygen. This may occur even when standard oxygen measurements appear normal.
Vasoconstriction
Vasoconstriction means blood vessels narrow. This can reduce blood flow to tissues and increase circulatory resistance.
Vasodilation
Vasodilation means blood vessels relax and widen. This improves blood flow, oxygen delivery, and tissue perfusion.
The information provided here is for educational purposes only and is not intended as medical advice. Some content discusses hypotheses and proposed biological mechanisms based on an integration of published research. It should not be used to diagnose, treat, cure, or prevent any medical condition. Use this information as a starting point for discussion with a qualified healthcare provider before making decisions about medications, supplements, devices, or changes to your health regimen. See full disclaimer and ai disclosure.
Example of Systemic Dysfunction
Hypothesis
Insulin Resistance — Why Treatment Does Not Always Stop Progression
Short Summary
This page explains why insulin resistance progresses even when blood sugar levels appear controlled. Carbon monoxide exposure generates fibrin amyloids that restrict tissue oxygen delivery. This ongoing oxygen deprivation drives intracellular lipid accumulation and impairs insulin signaling. Standard treatments do not reverse this structural blockage.
Normal Blood Glucose Values Do Not Indicate Cellular Recovery
Earlier stages of this metabolic decline remain invisible in standard testing, but this stage begins to appear in clinical measurements. Standard treatment improves glucose control and reduces insulin resistance. However, this does not mean the underlying cellular oxygen deprivation caused by fibrin amyloids has been resolved.
What Treatment Changes
Medication and lifestyle interventions target circulating markers. They reduce blood glucose levels, systemic insulin demand, and the incoming energy load. By lowering these external factors, treatment reduces the workload on the metabolic system.
Intracellular Oxygen Deprivation Persists
Standard treatment improves blood glucose measurements, but it does not correct the intracellular metabolic state. The cellular limitations persist despite improved lab results because the physical microvascular blockage remains in the blood vessels.
What Remains Unchanged Inside the Cell
Structural and functional limitations remain unchanged. Fibrin amyloids continue to restrict blood flow, keeping oxygen availability low. Consequently, mitochondrial capacity remains limited and the intracellular lipid load is not cleared.
Mechanisms of Continued Progression
Even if carbon monoxide exposure stops, existing fibrin amyloids remain and maintain a physical limit on cellular oxygen delivery. Because this limit is unchanged, normal daily energy demands exceed what aerobic energy production can support. Cellular recovery remains incomplete.
Continued Cellular Decline
This persistent mismatch between energy demand and oxygen-dependent capacity maintains an ongoing metabolic imbalance. The cellular condition continues to progress beneath improved clinical blood markers. If this process continues, it leads to type 2 diabetes.
Presence Across Chronic Diseases
This mechanism is not restricted to a single condition. The persistent oxygen deprivation caused by fibrin amyloids creates a shared pathway. Intracellular lipid accumulation, insulin resistance, and impaired energy metabolism appear across many chronic conditions.
Shared Mechanism Across Different Diagnoses
These conditions represent different manifestations of the same underlying process. The primary variable is where physiological compensation fails and how far the tissue dysfunction has advanced.
Conditions Driven by This Shared Pattern
This pattern occurs in:
Insulin resistance and type 2 diabetes • Metabolic syndrome and cardiovascular disease • Atherosclerosis and fatty liver disease • Obesity-related metabolic dysfunction • Chronic fatigue–related conditions • Post-viral syndromes • Neurodegenerative diseases • Polycystic ovary syndrome and chronic kidney disease
Tissue-Specific Clinical Presentation
The underlying mechanism remains consistent, but the clinical presentation depends on disease progression and which tissues experience the most severe localized oxygen deprivation.
Even if carbon monoxide exposure stops, persistent fibrin amyloids continue to restrict oxygen delivery, driving metabolic dysfunction forward despite standard treatments.
Sources
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://pmc.ncbi.nlm.nih.gov/articles/PMC7503727/
Pinti, M. V., Fink, G. K., Hathaway, Q. A., Durr, A. J., Kunovac, A., & Hollander, J. M. (2019). Mitochondrial dysfunction in type 2 diabetes mellitus: An organ-based analysis. American Journal of Physiology-Endocrinology and Metabolism, 316(2), E268–E285. https://journals.physiology.org/doi/full/10.1152/ajpendo.00314.2018
Snel, M., Jonker, J. T., Schoones, J., Lamb, H., de Roos, A., Smit, J. W. A., Meinders, A. E., Pijl, H., Romijn, J. A., & Jazet, I. M. (2012). Ectopic fat and insulin resistance: Pathophysiology and effect of diet and lifestyle interventions. International Journal of Endocrinology, 2012, 983814. https://pmc.ncbi.nlm.nih.gov/articles/PMC3366269/
Chen, Y., et al. (2025). Mitochondrial quality control in diabetes mellitus and its complications. Cell Death & Disease. https://www.nature.com/articles/s41419-025-07936-y
American Diabetes Association. (n.d.). Why type 2 diabetes progresses & medication changes over time. https://diabetes.org/living-with-diabetes/type-2/how-type-2-diabetes-progresses
site updates
The site is continuously updated.
Sources are under review, content will be added to existing topics, and more images will be brought to the site later.
NEW CONTENT COMING:
- News
– Rights to clean air
